2018 Antitrust M&A Year in Review
Client Alert | 1 min read | 03.01.19
Crowell & Moring LLP is pleased to release its "2018 Antitrust M&A Year in Review." Following a year of significant and industry-transforming transactions, this publication provides insight and analysis into developments and trends in global antitrust enforcement of mergers and acquisitions. We examine how changes, such as the first full-year of Trump administration appointments at the Antitrust Division and the seating of five new FTC Commissioners, have impacted the U.S. antitrust agencies’ enforcement priorities and policies. We also look at merger control in the EU, which saw a record-breaking number of filings in 2018.
The report spotlights areas that were particularly noteworthy in 2018, including telecom and media, health care, and policy changes regarding vertical mergers. We also take a look at the implications of China’s regulatory activity on merger control and its role in global merger review.
Given the likelihood that recent antitrust merger enforcement developments foreshadow what to expect in the coming year, the 2018 Antitrust M&A Year in Review provides insight into trends that will be highly relevant going forward. We hope that you will find this report useful and welcome your feedback.
Click here to access the report PDF.
Contacts
Insights
Client Alert | 10 min read | 04.22.26
The EU Industrial Accelerator Act Proposal’s Significance for the Automotive Industry
On March 4, 2026, the European Commission proposed the Industrial Accelerator Act (IAA), a draft regulation that aims to reverse the decline of the EU’s manufacturing sector while supporting the adoption of cleaner technologies. This client alert is the third in a three-part series dedicated to the IAA. In our first alert, we provided an overview of the draft regulation. In a second alert, we took a closer look at the new foreign direct investment (FDI) review framework that the IAA would establish for certain strategic sectors. In this third and final instalment of the series, we focus on the implications of the proposal for the automotive industry.
Client Alert | 3 min read | 04.21.26
Client Alert | 7 min read | 04.20.26
EU Pharma Package: The “Bolar” Exemption Compromise Proposal
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
